Boehringer Pharma Chief Confident Of Continued Success For Jardiance

SGLT2 Inhibitor Set For Further Expansion

 
• By Kevin Grogan
Carinne Brouillon
Carinne Brouillon • Source: Boehringer Ingelheim

More from Strategy

More from Business